Strong On High Relative Volume: Inogen (INGN)

Trade-Ideas LLC identified Inogen (INGN) as a strong on high relative volume candidate
By TheStreet Wire ,

Trade-Ideas LLC identified

Inogen

(

INGN

) as a strong on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Inogen as such a stock due to the following factors:

  • INGN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $10.2 million.
  • INGN has traded 155,066 shares today.
  • INGN is trading at 8.33 times the normal volume for the stock at this time of day.
  • INGN is trading at a new high 4.04% above yesterday's close.

'Strong on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as M&A events, material stock news, analyst upgrades, insider buying, buying from 'superinvestors,' or that hedge funds and momentum traders are piling into a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize. In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in INGN with the Ticky from Trade-Ideas. See the FREE profile for INGN NOW at Trade-Ideas

More details on INGN:

Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. INGN has a PE ratio of 108. Currently there are 5 analysts that rate Inogen a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for Inogen has been 292,100 shares per day over the past 30 days. Inogen has a market cap of $900.9 million and is part of the health care sector and health services industry. Shares are up 48.3% year-to-date as of the close of trading on Tuesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Inogen as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in net income. However, as a counter to these strengths, we also find weaknesses including premium valuation and weak operating cash flow.

Highlights from the ratings report include:

  • INGN's revenue growth has slightly outpaced the industry average of 37.3%. Since the same quarter one year prior, revenues rose by 44.9%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
  • INGN's debt-to-equity ratio is very low at 0.00 and is currently below that of the industry average, implying that there has been very successful management of debt levels. Along with this, the company maintains a quick ratio of 3.71, which clearly demonstrates the ability to cover short-term cash needs.
  • When compared to other companies in the Health Care Equipment & Supplies industry and the overall market, INOGEN INC's return on equity is below that of both the industry average and the S&P 500.
  • Net operating cash flow has decreased to $7.69 million or 18.96% when compared to the same quarter last year. Despite a decrease in cash flow INOGEN INC is still fairing well by exceeding its industry average cash flow growth rate of -42.51%.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Loading ...